{"schema_version":"1.0","hypothesis_id":37635,"triple":{"drug":"chelerythrine","drug_canonical":"chelerythrine","mediator":"TDP-43","mediator_canonical":"TDP-43","outcome":"ALS","outcome_canonical":"amyotrophic lateral sclerosis"},"domain":{"domain":"cross_domain","source":"rheumatoid_arthritis","target":"als"},"provenance_completeness":"partial_backfill","completeness_notes":"Backfilled retroactively from DB state on 2026-05-13. The pipeline_run this row references was created by the backfill script, not by the actual generation orchestrator. Source papers, claims, scoring, and embedding config are recovered; generation-time metadata (exact git commit at gen time, host, exact command) is not recoverable.","source_papers":[{"doi":"10.1146/annurev-genom-022024-011307","pmid":"42013476","year":2026,"roles":["mediator_outcome"],"title":"Cryptic Splicing in ALS: From Driving Disease Progression to Unlocking Novel Therapeutics","journal":"Annu Rev Genomics Hum Genet","work_id":144765,"publication_date":"2026-04-21"},{"doi":"10.1093/jnen/nlag017","pmid":"41851044","year":2026,"roles":["mediator_outcome"],"title":"Reduced nuclear TDP-43 and cytoplasmic DLK1 as markers of motor neuron degeneration in amyotrophic lateral sclerosis","journal":"J Neuropathol Exp Neurol","work_id":144402,"publication_date":"2026-03-19"},{"doi":"10.1523/jneurosci.0263-25.2026","pmid":"41813136","year":2026,"roles":["mediator_outcome"],"title":"ALS and Huntington Disease: Unraveling the Connections between TDP-43 and Huntingtin","journal":"J Neurosci","work_id":144263,"publication_date":"2026-03-11"},{"doi":"10.1016/j.conb.2025.103163","pmid":"41570741","year":2026,"roles":["mediator_outcome"],"title":"ALS-related proteinopathies: From TDP-43 to mitochondrial proteinopathies","journal":"Curr Opin Neurobiol","work_id":143760,"publication_date":"2026-01-21"},{"doi":"10.3390/antiox15010005","pmid":"41596063","year":2025,"roles":["mediator_outcome"],"title":"G-Quadruplexes Abet Neuronal Burnout in ALS and FTD","journal":"Antioxidants (Basel)","work_id":143523,"publication_date":"2025-12-19"},{"doi":"10.2174/0118715273374466250617085832","pmid":"40619651","year":2025,"roles":["mediator_outcome"],"title":"TDP-43 Proteinopathies in ALS and FTLD: Mechanistic Insights andTherapeutic Approaches","journal":"CNS Neurol Disord Drug Targets","work_id":136802,"publication_date":"2025-07-03"},{"doi":"10.3390/bios14120578","pmid":"39727843","year":2024,"roles":["mediator_outcome"],"title":"Development of a Sensitive and Reliable Meso Scale Discovery-Based Electrochemiluminescence Immunoassay to Quantify TDP-43 in Human Biofluids","journal":"Biosensors (Basel)","work_id":142410,"publication_date":"2024-11-28"},{"doi":"10.1016/j.heliyon.2024.e24672","pmid":"38304795","year":2024,"roles":["mediator_outcome"],"title":"Validation of a newly developed immunoassay for TDP-43 in human plasma","journal":"Heliyon","work_id":137618,"publication_date":"2024-01-01"},{"doi":"10.1016/j.nbd.2023.106245","pmid":"37527763","year":2023,"roles":["mediator_outcome"],"title":"A panel of TDP-43-regulated splicing events verifies loss of TDP-43 function in amyotrophic lateral sclerosis brain tissue","journal":"Neurobiol Dis","work_id":52659,"publication_date":"2023-07-30"},{"doi":"10.1212/wnl.0000000000201387","pmid":"36261296","year":2022,"roles":["mediator_outcome"],"title":"Finding Common Ground on the Site of Onset of Amyotrophic Lateral Sclerosis","journal":"Neurology","work_id":139883,"publication_date":"2022-10-19"},{"doi":"10.1080/14728222.2022.2083958","pmid":"35652285","year":2022,"roles":["mediator_outcome"],"title":"TAR DNA-binding protein of 43 kDa (TDP-43) and amyotrophic lateral sclerosis (ALS): a promising therapeutic target","journal":"Expert Opin Ther Targets","work_id":137594,"publication_date":"2022-06-02"},{"doi":"10.1001/jamaneurol.2022.1113","pmid":"35604654","year":2022,"roles":["mediator_outcome"],"title":"TDP-43 Accumulation Within Intramuscular Nerve Bundles of Patients With Amyotrophic Lateral Sclerosis","journal":"JAMA Neurol","work_id":50997,"publication_date":"2022-05-23"},{"doi":"10.3390/biom11121905","pmid":"34944548","year":2021,"roles":["mediator_outcome"],"title":"A Computational Approach to Investigate TDP-43 RNA-Recognition Motif 2 C-Terminal Fragments Aggregation in Amyotrophic Lateral Sclerosis","journal":"Biomolecules","work_id":54398,"publication_date":"2021-12-19"},{"doi":"10.1038/s42003-021-02621-0","pmid":"34548609","year":2021,"roles":["mediator_outcome"],"title":"Age-related demethylation of the TDP-43 autoregulatory region in the human motor cortex","journal":"Commun Biol","work_id":52284,"publication_date":"2021-09-21"},{"doi":"10.1186/s40478-020-01112-3","pmid":"33461623","year":2021,"roles":["mediator_outcome"],"title":"Spreading of TDP-43 pathology via pyramidal tract induces ALS-like phenotypes in TDP-43 transgenic mice","journal":"Acta Neuropathol Commun","work_id":51798,"publication_date":"2021-01-18"},{"doi":"10.11477/mf.1416201439","pmid":"31722315","year":2019,"roles":["mediator_outcome"],"title":"[Immunotherapy Against Misfolded Proteins in ALS].","journal":"Brain Nerve","work_id":138685,"publication_date":"2019-11-01"},{"doi":"10.11477/mf.1416201426","pmid":"31722302","year":2019,"roles":["mediator_outcome"],"title":"[Neuropathology of Amyotrophic Lateral Sclerosis].","journal":"Brain Nerve","work_id":138608,"publication_date":"2019-11-01"},{"doi":"10.1021/acs.biochem.9b00592","pmid":"31529970","year":2019,"roles":["mediator_outcome"],"title":"Using Tetracysteine-Tagged TDP-43 with a Biarsenical Dye To Monitor Real-Time Trafficking in a Cell Model of Amyotrophic Lateral Sclerosis","journal":"Biochemistry","work_id":54135,"publication_date":"2019-09-06"},{"doi":"10.1038/s41598-018-20565-0","pmid":"29396541","year":2018,"roles":["drug_mediator"],"title":"TDP-43 self-interaction is modulated by redox-active compounds Auranofin, Chelerythrine and Riluzole","journal":"Sci Rep","work_id":289068,"publication_date":"2018-01-29"},{"doi":"10.1186/s13287-018-1048-1","pmid":"30442180","year":2018,"roles":["mediator_outcome"],"title":"Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells","journal":"Stem Cell Res Ther","work_id":51514,"publication_date":"2018-11-15"},{"doi":"10.3389/fnins.2018.00487","pmid":"30072868","year":2018,"roles":["mediator_outcome"],"title":"Pathological Proteins Are Transported by Extracellular Vesicles of Sporadic Amyotrophic Lateral Sclerosis Patients","journal":"Front Neurosci","work_id":50220,"publication_date":"2018-07-19"},{"doi":"10.1371/journal.pone.0172246","pmid":"28282387","year":2017,"roles":["mediator_outcome"],"title":"The essential and downstream common proteins of amyotrophic lateral sclerosis: A protein-protein interaction network analysis","journal":"PLoS One","work_id":137114,"publication_date":"2017-03-10"},{"doi":"10.1159/000478979","pmid":"28848086","year":2017,"roles":["mediator_outcome"],"title":"Cerebrospinal Fluid TAR DNA-Binding Protein 43 Combined with Tau Proteins as a Candidate Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Spectrum Disorders","journal":"Dement Geriatr Cogn Disord","work_id":132207,"publication_date":"2017-01-01"},{"doi":"10.1093/hmg/ddw247","pmid":"27466204","year":2016,"roles":["mediator_outcome"],"title":"Enhancing survival motor neuron expression extends lifespan and attenuates neurodegeneration in mutant TDP-43 mice","journal":"Hum Mol Genet","work_id":52096,"publication_date":"2016-07-27"},{"doi":"10.1038/srep39490","pmid":"28000730","year":2016,"roles":["mediator_outcome"],"title":"An acridine derivative, [4,5-bis{(N-carboxy methyl imidazolium)methyl}acridine] dibromide, shows anti-TDP-43 aggregation effect in ALS disease models","journal":"Sci Rep","work_id":51492,"publication_date":"2016-12-21"},{"doi":"10.1038/srep23281","pmid":"26980269","year":2016,"roles":["mediator_outcome"],"title":"Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains","journal":"Sci Rep","work_id":50195,"publication_date":"2016-03-16"},{"doi":null,"pmid":"26689008","year":2015,"roles":["mediator_outcome"],"title":"[RNA processing TDP-43 protein has a main pathological role in FTLD and ALS].","journal":"Postepy Biochem","work_id":140052,"publication_date":"2015-01-01"},{"doi":"10.1186/s40478-014-0181-z","pmid":"25637145","year":2015,"roles":["mediator_outcome"],"title":"Early detection of structural abnormalities and cytoplasmic accumulation of TDP-43 in tissue-engineered skins derived from ALS patients","journal":"Acta Neuropathol Commun","work_id":51441,"publication_date":"2015-01-30"},{"doi":"10.1083/jcb.201504057","pmid":"26598621","year":2015,"roles":["mediator_outcome"],"title":"TDP-43 is intercellularly transmitted across axon terminals","journal":"J Cell Biol","work_id":50081,"publication_date":"2015-11-23"}],"source_paper_count":29,"extracted_claims":[{"side":"drug_mediator","object":"TDP-43","context":"self-interaction","subject":"chelerythrine","work_id":289068,"claim_id":216270,"polarity":"positive","predicate":"inhibits","confidence":0.95,"extraction_run_id":29},{"side":"mediator_outcome","object":"ALS","context":"in pathological aggregates","subject":"TDP-43","work_id":50081,"claim_id":27501,"polarity":"positive","predicate":"associated_with","confidence":0.9,"extraction_run_id":15},{"side":"mediator_outcome","object":"ALS","context":"in amyotrophic lateral sclerosis brains","subject":"TDP-43","work_id":50195,"claim_id":27772,"polarity":"positive","predicate":"associated_with","confidence":0.9,"extraction_run_id":15},{"side":"mediator_outcome","object":"ALS","context":"in microvesicles (MVs) from plasma of sporadic ALS patients compared to healthy controls","subject":"TDP-43","work_id":50220,"claim_id":27851,"polarity":"positive","predicate":"correlates_with","confidence":0.8,"extraction_run_id":15},{"side":"mediator_outcome","object":"ALS","context":"in nerve bundles as diagnostic biomarker","subject":"TDP-43","work_id":50997,"claim_id":29682,"polarity":"positive","predicate":"associated_with","confidence":0.85,"extraction_run_id":15},{"side":"mediator_outcome","object":"ALS","context":"in tissue-engineered skins derived from ALS patients","subject":"TDP-43","work_id":51441,"claim_id":30619,"polarity":"positive","predicate":"associated_with","confidence":0.7,"extraction_run_id":15},{"side":"mediator_outcome","object":"ALS","context":"in neuronal cells","subject":"TDP-43","work_id":51492,"claim_id":30752,"polarity":"positive","predicate":"associated_with","confidence":0.95,"extraction_run_id":15},{"side":"mediator_outcome","object":"ALS","context":"in surviving motor neurons from ALS patients","subject":"TDP-43","work_id":51514,"claim_id":30797,"polarity":"positive","predicate":"associated_with","confidence":0.9,"extraction_run_id":15},{"side":"mediator_outcome","object":"ALS","context":"in patients with sporadic amyotrophic lateral sclerosis","subject":"TDP-43","work_id":51798,"claim_id":31451,"polarity":"positive","predicate":"associated_with","confidence":0.8,"extraction_run_id":15},{"side":"mediator_outcome","object":"ALS","context":"in mutant TDP-43 mice model","subject":"TDP-43","work_id":52096,"claim_id":32007,"polarity":"positive","predicate":"causes","confidence":0.85,"extraction_run_id":15},{"side":"mediator_outcome","object":"ALS","context":"in motor cortex","subject":"TDP-43","work_id":52284,"claim_id":32407,"polarity":"positive","predicate":"associated_with","confidence":0.95,"extraction_run_id":15},{"side":"mediator_outcome","object":"ALS","context":"in brain tissue","subject":"TDP-43","work_id":52659,"claim_id":33053,"polarity":"positive","predicate":"associated_with","confidence":0.9,"extraction_run_id":15},{"side":"mediator_outcome","object":"ALS","context":"as major constituent of proteinaceous inclusions","subject":"TDP-43","work_id":54135,"claim_id":35515,"polarity":"positive","predicate":"associated_with","confidence":0.95,"extraction_run_id":15},{"side":"mediator_outcome","object":"ALS","context":"human","subject":"TDP-43","work_id":54398,"claim_id":35872,"polarity":"positive","predicate":"associated_with","confidence":0.8,"extraction_run_id":15},{"side":"mediator_outcome","object":"ALS","context":"cerebrospinal fluid","subject":"TDP-43","work_id":132207,"claim_id":98014,"polarity":"positive","predicate":"associated_with","confidence":0.9,"extraction_run_id":21},{"side":"mediator_outcome","object":"ALS","context":"in ALS and FTLD","subject":"TDP-43","work_id":136802,"claim_id":99137,"polarity":"positive","predicate":"associated_with","confidence":0.9,"extraction_run_id":21},{"side":"mediator_outcome","object":"ALS","context":"in protein-protein interaction network analysis of classical ALS and ALS+FTD","subject":"TDP-43","work_id":137114,"claim_id":99608,"polarity":"positive","predicate":"associated_with","confidence":0.7,"extraction_run_id":21},{"side":"mediator_outcome","object":"ALS","context":"in 97% of ALS cases","subject":"TDP-43","work_id":137594,"claim_id":100211,"polarity":"positive","predicate":"associated_with","confidence":0.9,"extraction_run_id":21},{"side":"mediator_outcome","object":"ALS","context":"initiation and progression of ALS","subject":"TDP-43","work_id":137594,"claim_id":100212,"polarity":"positive","predicate":"associated_with","confidence":0.7,"extraction_run_id":21},{"side":"mediator_outcome","object":"ALS","context":"human plasma","subject":"TDP-43","work_id":137618,"claim_id":100239,"polarity":"positive","predicate":"associated_with","confidence":0.85,"extraction_run_id":21},{"side":"mediator_outcome","object":"ALS","context":"in sporadic ALS","subject":"TDP-43","work_id":138608,"claim_id":101035,"polarity":"positive","predicate":"associated_with","confidence":0.85,"extraction_run_id":21},{"side":"mediator_outcome","object":"ALS","context":"in sporadic ALS","subject":"TDP-43","work_id":138685,"claim_id":101095,"polarity":"positive","predicate":"causes","confidence":0.95,"extraction_run_id":21},{"side":"mediator_outcome","object":"ALS","context":"in patients with ALS and FTD","subject":"TDP-43","work_id":139883,"claim_id":101653,"polarity":"positive","predicate":"associated_with","confidence":0.6,"extraction_run_id":21},{"side":"mediator_outcome","object":"ALS","context":"in Amyotrophic Lateral Sclerosis cases","subject":"TDP-43","work_id":140052,"claim_id":101702,"polarity":"positive","predicate":"associated_with","confidence":0.9,"extraction_run_id":21},{"side":"mediator_outcome","object":"ALS","context":"in blood of ALS patients compared to healthy controls","subject":"TDP-43","work_id":142410,"claim_id":101940,"polarity":"negative","predicate":"associated_with","confidence":0.95,"extraction_run_id":21},{"side":"mediator_outcome","object":"ALS","context":"methionine alterations","subject":"TDP-43","work_id":143523,"claim_id":102745,"polarity":"positive","predicate":"associated_with","confidence":0.8,"extraction_run_id":21},{"side":"mediator_outcome","object":"ALS","context":"","subject":"TDP-43","work_id":143760,"claim_id":102909,"polarity":"positive","predicate":"associated_with","confidence":0.8,"extraction_run_id":21},{"side":"mediator_outcome","object":"ALS","context":"in 97% of ALS cases","subject":"TDP-43","work_id":144263,"claim_id":103326,"polarity":"positive","predicate":"associated_with","confidence":0.95,"extraction_run_id":21},{"side":"mediator_outcome","object":"ALS","context":"in upper and lower motor neurons","subject":"TDP-43","work_id":144402,"claim_id":103437,"polarity":"positive","predicate":"associated_with","confidence":0.8,"extraction_run_id":21},{"side":"mediator_outcome","object":"ALS","context":"amyotrophic lateral sclerosis","subject":"TDP-43","work_id":144765,"claim_id":103773,"polarity":"positive","predicate":"associated_with","confidence":0.9,"extraction_run_id":21}],"extracted_claim_count":30,"extraction":{"model":"deepseek-v4-flash","model_source":"configured","prompt_version":"v1_2026_05_07","run_ids":[15,21,29]},"bridge":{"a_to_b_predicate":"inhibits","b_to_c_predicate":"associated_with","a_to_b_evidence_count":1,"b_to_c_evidence_count":29,"edge_support_log_ab":0.6931471805599453,"edge_support_log_bc":3.4011973816621555,"novelty_factor":1.0,"direct_a_to_c_count":0},"embedding":{"model":"bge-m3","dim":1024,"max_length":8192,"similarity_scores":{}},"scoring":{"method":"swanson_abc_log_evidence_with_novelty_penalty","formula":"score = min((log(ab+1) + log(bc+1)) * novelty / 10, 1.0); novelty = 1.0 if direct==0 else 0.7 / (direct+1)","score_raw":0.40943445622221003,"score":0.40943445622221003,"quality_tier":"high","quality_reason":null},"pipeline_run":{"id":4,"run_uuid":"eb8b7730-d92e-4cd5-95dd-95f6c5d62cc2","command":"scripts/backfill_provenance_v2.py:v2_2026_05_12","status":"completed","git_commit":"9996ffaa56e9b7cd5f677bd8203624c2c18aa000","host":"MacBook-Pro-Daniel96.local","started_at":"2026-05-12T21:35:53.363326+00:00","ended_at":"2026-05-12T21:43:41.903387+00:00","notes":"Retroactive provenance backfill on 2026-05-13 for snapshot v2_2026_05_12. Synthetic pipeline_runs row — original generation run records are lost (pre-date provenance schema). All recoverable fields populated from current DB state (claims, works, repurposing_hypotheses); pipeline_run record is synthetic, hence completeness='partial_backfill'.\nBackfilled 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.\nRefreshed 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.\nRefreshed 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.","domains":["als","alzheimer","depression","epilepsy","glioblastoma","inflammatory_bowel_disease","multiple_sclerosis","pancreatic_cancer","rheumatoid_arthritis","type_2_diabetes"]},"generated_at":"2026-05-12T21:43:40.945575+00:00"}